Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hauber

Showing results (621-630 of 854) with videos related to

Pageof 86
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 8, 2016
A Framework for Incorporating Patient Preferences Regarding Benefits and Risks into Regulatory Assessment of Medical TechnologiesMartin Ho, Anindita Saha, K Kimberly McCleary, et al.
Journal of Medical Economics|July 20, 2012
Patients rank toxicity against progression free survival in second-line treatment of advanced renal cell carcinomaMichael K Wong, Ateesha F Mohamed, A Brett Hauber, et al.
Proceedings. Biological Sciences|August 10, 2012
Visual accommodation and active pursuit of prey underwater in a plunge-diving bird: the Australasian gannetGabriel E Machovsky-Capuska, Howard C Howland, David Raubenheimer, et al.
BMC Medical Informatics and Decision Making|January 7, 2021
A revealed preference analysis to develop composite scores approximating lung allocation policy in the U.SDarren E Stewart, Dallas W Wood, James B Alcorn, et al.
Plos One|June 8, 2012
Formation of trans-activation competent HIV-1 Rev:RRE complexes requires the recruitment of multiple protein activation domainsDirk Hoffmann, Doreen Schwarck, Carina Banning, et al.
European Journal of Pharmacology|October 2, 2022
Pro-cognitive effects of the GlyT1 inhibitor Bitopertin in rodentsSerena Deiana, Wolfgang Hauber, Alexandra Munster, et al.
Plos One|June 25, 2016
Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator SystemsJulia K Bialek, Gábor A Dunay, Maike Voges, et al.
Amino Acids|December 2, 2009
Down-regulation of hypusine biosynthesis in Plasmodium by inhibition of S-adenosyl-methionine-decarboxylaseRobert Blavid, Peter Kusch, Joachim Hauber, et al.
Science Advances|October 8, 2025
Dust devil migration patterns reveal strong near-surface winds across MarsValentin T Bickel, Miguel Almeida, Matthew Read, et al.
BMC Infectious Diseases|April 19, 2024
Key informant views on potential acceptability and feasibility of long-acting antiretroviral treatment for HIV in KenyaAnne Kaggiah, Catherine N Maina, John Kinuthia, et al.
Pageof 86

Showing results (621-630 of 854) with videos related to

Sort By:
Pageof 86
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 8, 2016
A Framework for Incorporating Patient Preferences Regarding Benefits and Risks into Regulatory Assessment of Medical TechnologiesMartin Ho, Anindita Saha, K Kimberly McCleary, et al.
Journal of Medical Economics|July 20, 2012
Patients rank toxicity against progression free survival in second-line treatment of advanced renal cell carcinomaMichael K Wong, Ateesha F Mohamed, A Brett Hauber, et al.
Proceedings. Biological Sciences|August 10, 2012
Visual accommodation and active pursuit of prey underwater in a plunge-diving bird: the Australasian gannetGabriel E Machovsky-Capuska, Howard C Howland, David Raubenheimer, et al.
BMC Medical Informatics and Decision Making|January 7, 2021
A revealed preference analysis to develop composite scores approximating lung allocation policy in the U.SDarren E Stewart, Dallas W Wood, James B Alcorn, et al.
Plos One|June 8, 2012
Formation of trans-activation competent HIV-1 Rev:RRE complexes requires the recruitment of multiple protein activation domainsDirk Hoffmann, Doreen Schwarck, Carina Banning, et al.
European Journal of Pharmacology|October 2, 2022
Pro-cognitive effects of the GlyT1 inhibitor Bitopertin in rodentsSerena Deiana, Wolfgang Hauber, Alexandra Munster, et al.
Plos One|June 25, 2016
Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator SystemsJulia K Bialek, Gábor A Dunay, Maike Voges, et al.
Amino Acids|December 2, 2009
Down-regulation of hypusine biosynthesis in Plasmodium by inhibition of S-adenosyl-methionine-decarboxylaseRobert Blavid, Peter Kusch, Joachim Hauber, et al.
Science Advances|October 8, 2025
Dust devil migration patterns reveal strong near-surface winds across MarsValentin T Bickel, Miguel Almeida, Matthew Read, et al.
BMC Infectious Diseases|April 19, 2024
Key informant views on potential acceptability and feasibility of long-acting antiretroviral treatment for HIV in KenyaAnne Kaggiah, Catherine N Maina, John Kinuthia, et al.
Pageof 86